Compounds That Target CDC42BPB

CDC42 binding protein kinase beta · 17 compounds in BiohacksAI corpus

CDC42BPB (CDC42 binding protein kinase beta) is a biological target with 17 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into CDC42BPB modulation for therapeutic and biohacking applications.

View CDC42BPB target page →UniProt: Q9Y5S2 ↗

Most Studied Compounds for CDC42BPB

Dasatinib

299+

studies

Axitinib

298+

studies

All 17 Compounds — Ranked by Evidence

Sb 203580

4.92

confidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Vandetanib

4.30

confidence

Nilotinib

4.17

confidence

Doramapimod

4.06

confidence

Sb 202190

3.64

confidence

Tae 684

3.43

confidence

Lestaurtinib

3.04

confidence

Gsk 690693

2.64

confidence

Zotiraciclib

2.56

confidence

Decernotinib

2.20

confidence

Y 39983

2.20

confidence

Ucn 01

1.79

confidence

Sar 407899 Free Base

1.79

confidence

Axitinib

298+

studies

0.69

confidence

Dasatinib

299+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CDC42BPB (CDC42 binding protein kinase beta). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CDC42BPB target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.